Cargando…
Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy
OBJECTIVE: Perampanel is an oral anti‐seizure medication, which is approved in Japan for focal‐onset seizures, with/without focal to bilateral tonic–clonic seizures, as monotherapy/adjunctive therapy in patients aged 4 years and older. Treatment for generalized tonic–clonic seizures as adjunctive th...
Autores principales: | Hanaya, Ryosuke, Kubota, Yuichi, Mizobuchi, Masahiro, Iida, Koji, Ono, Tomonori, Motooka, Hiromichi, Nakano, Naoki, Fujimoto, Ayataka, Iwasaki, Masaki, Fukuda, Masafumi, Kondo, Akihiko, Uruno, Katsuhisa, Yamamuro, Shintaro, Yamaguchi, Kohei, Onishi, Kisaki, Ngo, Leock Y, Inoue, Yushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690696/ https://www.ncbi.nlm.nih.gov/pubmed/37547978 http://dx.doi.org/10.1002/epi4.12804 |
Ejemplares similares
-
Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study
por: Hussein, Ziad, et al.
Publicado: (2022) -
Time to exceed pre‐randomization monthly seizure count for perampanel in participants with primary generalized tonic–clonic seizures: A potential clinical end point
por: Kerr, Wesley T., et al.
Publicado: (2022) -
Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures
por: Fogarasi, Andras, et al.
Publicado: (2020) -
Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open‐label Study 342 (FREEDOM)
por: Husni, Ryan Edbert, et al.
Publicado: (2021) -
Anti-tumor effects of perampanel in malignant glioma cells
por: Tatsuoka, Juri, et al.
Publicado: (2022)